Product information
- Product Line
- Human Formulations
- Category
- Therapeutic Ranges, Diabetic Range
- Dosage Form
- Tablet
- Product Type
- Single Ingredient
Available strengths
Voglibose O.3mg + Metformin 500mg . ( )
Description
Voglibose O.3mg + Metformin 500mg Tab. (Uncoated) is a tablet formulated with Voglibose O.3mg + Metformin 500mg . ( ). The listed active ingredient profile is Voglibose O; Metformin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicines used in clinician-directed management of type 2 diabetes mellitus. The source identifies the dosage form as tablet with uncoated presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.